FindTrial
Sign In

Immunomodulatory activity of SuvarnaBindu prashana in Children

"Open labelled comparative clinical study to evaluate the Immunomodulatory activity of SuvarnaBindu Prashana in Children"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027697
Enrollment
30
Registered
2020-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: SuvarnaBindu Prashana: Suvarnabindu prashana will be administered daily, orally for 30 days Dose 1 year to 2 year, 2 drops 2 year to 3 year, 4 drops 3 year to 4 year, 6 drops 4 year t

Sponsors

Shri BMK Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Freshly enrolled cases of apparently healthy children of age group 12 ââ?¬â?? 58 months at the time of inclusion.

Exclusion criteria

Exclusion criteria: Who had already taken Suvarnabindu prashana either in KLE ayurveda hospital or any other centres. During examination, if it is found that the subject is on any medication like antiepileptic etc. drugs which will affect the expected outcome of the study. Children who are under nourished and malnourished will be excluded.

Design outcomes

Primary

MeasureTime frame
There may be significant effect of Suvarnabindu prashana on Immuno-modulatory activity.Timepoint: 35 days—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Abhishek S

Shri BMK Ayurved Mahavidyalaya

azizarbar@gmail.com9844532113

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026